No significant between-group differences were seen for low-volume versus high-volume split-dose regimens in adequacy of bowel cleansing, while low-volume regimens had higher odds of patient adherence or completion, tolerability, and willingness to repeat.
Active choice interventions in an EHR prompted an increase in ordering of cancer screenings but not patient follow-through, while physicians who themselves underwent colorectal cancer (CRC) screening had more patients do so as well.
The update from endocrinology, obesity, surgery, anesthesiology, and nutrition experts covers perioperative nutritional, metabolic, and nonsurgical support of patients undergoing bariatric procedures.
In response to the detection of N-nitrosodimethylamine, a probable carcinogen, several companies have recalled the histamine H2 receptor antagonist, although FDA testing has found that levels detected are low.
While the FDA has previously cleared duodenoscopes with removable endcap components, the device is the first to have a disposable elevator component, a part that has been traditionally difficult to clean and reprocess.
For asymptomatic, average-risk patients ages 50 to 75 years, the guidance suggests use of a fecal immunochemical test (FIT) or high-sensitivity guaiac-based fecal occult blood test every two years, colonoscopy every 10 years, or flexible sigmoidoscopy every 10 years plus FIT every two years.
While fecal microbiota transplantation (FMT) was associated with fewer bloodstream infections than antibiotics in one study, a brief report described two cases of drug-resistant bacteremia transmitted by FMT.